 SOMERSET, N.J.-- BUSINESS WIRE --Catalent, Inc. NYSE: CTLT, the global leader in enabling pharma, biotech, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that it will release financial results for the second quarter of fiscal year 2023 ended December 31, 2022, before the market open on Tuesday, February 7, 2023. The Companys management will host a webcast to discuss the results at 8:15 a.m. ET on the same day. 